Investigational Site Number 250003

Nîmes 30029

0 studies enrolling now · 1 studies all time

What they study most

Hematopoietic Neoplasm

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early